Immunohistochemical analysis of the tumor tissues revealed a statistically significant (P-value < 0.05) reduction in staining for HSP70, MYC, BRD4, and αSMA (Fig. 3f, g) in Minnelide-treated mice. This evidence concerns the gene BRD4 and neoplasm.